Houman Sotoudeh

Houman Sotoudeh: MRI Math, AI Platform-Cyber Device for GBM is now FDA-approved

Houman Sotoudeh, Associate Professor of Neuroradiology and Neurology at University of Alabama at Birmingham, shared on X:

“I’m thrilled to share that the AI Platform-Cyber Device for glioblastoma multiforme (GBM), which I had the privilege of helping to develop, is now FDA-approved and commercially available!”

Additional information.
Source: Houman Sotoudeh/X

AI cancer FDA GBM glioblastoma multiforme Houman Sotoudeh MRI Math OncoDaily Oncology University of Alabama at Birmingham